Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18339141 | 1.00 | EPHX1 (0.48) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL18339140 | 1.00 | EPHX1 (0.48) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL11241826 | 0.98 | EPHX1 (0.52) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL11255010 | 0.98 | EPHX1 (0.52) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL11251244 | 0.93 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL11245616 | 0.84 | EPHX1 (0.52) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL11251253 | 0.83 | EPHX1 (0.35) | EPHX1 | |
| SCHEMBL28581095 | 0.81 | ALDH1A1 (0.45) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL28238221 | 0.81 | ALDH1A1 (0.45) | EPHX1ALDH1A1CYP1A2SPHK1SPHK2 | |
| SCHEMBL1306960 | 0.79 | EPHX1 (0.31) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | PROCTER & GAMBLE (US) | 2020-05-14 | — | — | US | claimed |
| US-10568825-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-02-25 | — | — | US | claimed |
| US-20170267944-A1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-09-21 | — | — | US | claimed |
| EP-3139902-A2 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2017-03-15 | — | — | EP | claimed |
| US-20150322376-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-11-12 | — | — | US | claimed |
| WO-2015171738-A2 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-12 | — | — | WO | claimed |
| EP-2931235-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931238-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931854-A1 | FRAGRANCE MATERIALS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| US-20140179748-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMAPNY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093828-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093748-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-12636240-B2 | Antiperspirant composition | COTY INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12533302-B2 | Systems and methods for delivery of actives and healing tissue | VIAS PARTNERS, LLC | 2026-01-27 | — | — | US | disclosed |
| US-4364400-A | 1,3-OXATHIANE AND 1,3-OXATHIOLANE DERIVATIVES | FIRMENICH SA (CH) | 1982-12-21 | — | — | US | disclosed |
| US-4262030-A | 1,3-OXATHIANE AND 1,3-OXATHIOLANE DERIVATIVES | FIRMENICH SA (CH) | 1981-04-14 | — | — | US | disclosed |
| US-4220561-A | Oxathiane and oxathiolane derivatives as perfuming agents | FIRMENICH SA (CH) | 1980-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568825-B2 | Antiperspirant and deodorant compositions | DEK, QDPR, GPX4 | EPHX1 867/4885ALDH1A1 726/4885CYP1A2 875/4885 |
| US-20140170102-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | EPHX1 867/4885ALDH1A1 726/4885CYP1A2 875/4885 |
| US-12533302-B2 | Systems and methods for delivery of actives and healing tissue | EXOSC10, PDGFA, EXOSC9 | EPHX1 2941/4885ALDH1A1 2173/4885CYP1A2 4537/4885 |
| US-20200146960-A1 | Antiperspirant and Deodorant Compositions | DEK, QDPR, GPX4 | EPHX1 867/4885ALDH1A1 726/4885CYP1A2 875/4885 |
| US-12636240-B2 | Antiperspirant composition | OPRD1, DRD2, TAS2R40 | EPHX1 1562/4885ALDH1A1 1619/4885CYP1A2 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.